Windlas Biotech that Board of Directors at its Meeting held on Wednesday, September 8, 2021, has approved the Unaudited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2021. Pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015, the company has enclosed: Unaudited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2021 and Limited Review Report on Standalone and Consolidated Financial Results for the Quarter ended June 30, 2021. Further, the Company has already made necessary arrangement to publish the same in the Newspapers as required under the SEBI (LODR) Regulations, 2015. The meeting of the Board of Directors commenced at 1:00 pm and concluded at 2.25 pm.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1504.75 |
Dr. Reddys Lab | 6045.00 |
Cipla | 1540.70 |
Zydus Lifesciences | 1096.45 |
Lupin | 1607.00 |
View more.. |